A health care company whose shares are up 57% in the past year and which, unlike many other health care companies, is not threatened by the possibility of a “Medicare for All” type system (in fact, it could actually benefit from a national health insurance model) leads a selection of stocks that have risen sharply (50% or more) in the past 12 months and appear to have the potential for further gains. For these stocks that may be worthy of consideration, CLICK HERE.
“Very few people have gotten rich on their seventh best idea, but a lot of people have gotten rich with their best idea,” Warren Buffett is quoted as having said – and today’s article looks at what two big-name money managers appear to consider among their best investment ideas, based on the fact that they have substantial portions of their portfolios tied up in these single stocks. For these two potential “best idea” investments – a health care stock and a memory chip maker stock – CLICK HERE.
With only 10% of drug candidates that reach the clinical trial stage eventually making their way onto the market, knowing which small biotechs to bet on for big gains is no easy feat for investors. The author of today’s article suggests that one way investors can increase their odds of success is by identifying small biotechs that are getting the attention (and money) of big pharma companies. He proceeds to highlight one such company, which “has developed an innovative product that makes other drugs more effective” – attracting capital from the likes of Roche, Johnson & Johnson and more. To read about this company, the science behind its technology – and the opportunity for investors – CLICK HERE.